BPA for cinryze, kalbitor, takhyzro, elaprase, vpriv, adzynma, livtencity, and gattex
Active Awarded Last action
- Contract number
- 36E79726A0023
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI DDEVYUAXJ624
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 16% complete
- IDV ceiling
- $231,177,456.85
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center, on behalf of the Department of Veterans Affairs, established a single-award Blanket Purchase Agreement with Takeda Pharmaceuticals America, Inc. on August 28, 2026, against the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB), with a ceiling of $231.2 million and an ultimate completion date of August 27, 2027.
The BPA covers eight pharmaceutical products: CINRYZE, KALBITOR, TAKHYZRO, ELAPRASE, VPRIV, ADZYNMA, LIVTENCITY, and GATTEX, streamlining delivery orders across Veterans Integrated Service Networks and authorized federal healthcare entities without requiring individual competitive procurements.
Place of performance is Lexington, Massachusetts and Brooks, Kentucky. Work involves delivery of pre-negotiated, single-source biopharmaceutical products according to specification. Recent delivery order activity reflects concentration at VA medical centers and federal correctional facilities: a $107,540 order to Veterans Integrated Service Network 20 for Gammagard Liquid in April 2026, a $548,689 order to the Federal Correctional Institution Fort Worth for pharmacy services in April 2026, and a $204,577 order to Fort Worth for pharmacy operations covering January through September 2026 in February 2026.
Quick answers
Who was awarded contract 36E79726A0023?
36E79726A0023 was awarded to Takeda Pharmaceuticals America, Inc. by National Acquisition Center (Headquarters) on August 28, 2026.
How much is contract 36E79726A0023 worth?
36E79726A0023's own ceiling is $231,177,457.
Who can order from contract 36E79726A0023?
36E79726A0023 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79726A0023 under another contract?
Yes. 36E79726A0023 is a blanket purchase agreement under 36F79726D0181, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79726A0023 competed?
The extent of competition for 36E79726A0023 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV